The Global Fertility Drug and Surgery Market Share Is expected to grow with a strong CAGR of 9.8% over the forecast period from 2018 to 2023. Infertility is a reproductive problem in which the patient could not conceive the baby. Infertility may cause due to the problem in the reproductive system of either partner.
The global fertility drug and surgery market is profiled in great detail in the report, which reveals the historical growth trajectory of the market in detail in order to make sense of the market’s current position and likely future growth prospects.
GET Free Sample PDF: https://www.marketresearchfuture.com/sample_request/7588
Fertility drugs and surgery are used when a couple can’t conceive through natural means. The problems with fertility are diverse and can occur with both men and women, making the field difficult to navigate and important. Fertility healthcare has been one of the most prominent and laudable offshoots of the healthcare sector over the last few decades, as it has allowed several couples who wouldn’t have otherwise conceived to conceive and have children. Modern healthcare has allowed for the development of effective treatments for both male and female infertility, leading to the fertility drug and surgery market taking on an important position.
The increasing awareness about fertility drugs and surgery is likely to be a major driver for the global fertility drug and surgery market over the forecast period. While fertility problems have been a constant for a number of years, the development of more effective treatments has resulted in a high volume of customers enjoying the miracles of modern medicine. The increasing prevalence of a sedentary lifestyle is also likely to be a key driver for the global fertility drug and surgery market, as sedentary lifestyles are said to be a key causative agent for infertility problems.
Top Key Players:
Leading players in the global fertility drug and surgery market include –
Merck & Co. Pharmaceutical Company
Noven Pharmaceuticalorganon Inc.
Janssen Pharmaceuticals Inc.
Personal Products Company
Baxter Healthcare Corporation
Ferring Pharmaceuticals Inc.
Procter & Gamble Pharmaceuticals
Emd Serono Inc.
- In October 2019, the Sheffield Teaching Hospitals NHS Foundation Trust in Yorkshire received a GBP 1.78 million grant to conduct a trial examining the way women suffering from side effects of fertility treatments are treated.
Global Fertility Drug and Surgery Market Segmentation:
The global market is segmented on the basis of cause, drug, procedures, end user, and region. On the basis of the underlying cause, the global fertility drug and surgery market is segmented into male and female.
By Drug: Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment, Gonadotrophins, Aromatase Inhibitors, Estrogen Receptor Modulators, Dopamine Agonists, Metformin Hydrochloride, And Others.
By Procedures: Hysteroscopy, Laparoscopy And Robotic Laparoscopy, Laparotomy/Open Surgery, Egg Retrieval, Varicocelectomy, Vasectomy Reversal (Vasovasostomy Or Vasoepididymostomy), And Sperm Retrieval (Epididymal Aspiration).
By End User: Fertility Clinics, Hospitals, Clinical Research Institutes, And Others.
Ask for an Exclusive Discount: https://www.marketresearchfuture.com/check-discount/7588
The Americas are the dominant regional market in the global fertility drug and surgery market, followed by Europe. The growing prevalence of sedentary lifestyles and obesity in the Americas, particularly in the U.S., is likely to be a major driver for the fertility drug and surgery market in the Americas over the forecast period. Asia Pacific is also likely to be a strong segment over the forecast period due to the growing awareness about women’s health and fertility treatments in the region.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Fertility Drug And Surgery Market, By Underlying Cause
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312